Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Quetiapine fumarate, Seroquel
Quetiapine · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Quetiapine fumarate tablets 300 mg | EXPERIMENTAL | Quetiapine fumarate film-coated tablets 300 mg of Dr. Reddy's Laboratories Limited |
| Seroquel | ACTIVE_COMPARATOR | Seroquel film-coated tablets 300 mg of Astrazeneca Pharmaceuticals, USA |
| Name | Type | Description |
|---|---|---|
| Quetiapine fumarate | DRUG | Quetiapine fumarate tablets 300mg |
Inclusion Criteria: * Written informed consent for participation in the study by the patient and Patient's Legally Acceptable Representative (LAR). If the patient or his/her legally acceptable representative is unable to read/write - an impartial witness should be present during the entire informed...
Quetiapine is a small molecule drug candidate developed by Dr. Reddy's Laboratories Ltd, which trades under the ticker RDY. It is also known as quetiapine fumarate. The drug is currently in Phase 1 clinical development, and its specific indications are undisclosed.
Quetiapine targets the serotonin receptor HTR2A, the dopamine receptor DRD2, and the serotonin receptor HTR2C. It acts as an antagonist at these targets. This mechanism of action is characteristic of its pharmacological class.
Quetiapine is being developed by Dr. Reddy's Laboratories Ltd, a pharmaceutical company that trades under the ticker symbol RDY. The company is responsible for the clinical development of this drug candidate.
Quetiapine is in Phase 1 clinical development. It is an investigational drug and has not been approved by the FDA. The development program includes one completed Phase 1 trial.
Quetiapine has been studied in one completed Phase 1 clinical trial, NCT01566487, titled 'Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition.' This trial enrolled 54 healthy volunteers in India and was active-controlled and randomized.
Yes, Quetiapine is also known as quetiapine fumarate. The two names refer to the same drug candidate developed by Dr. Reddy's Laboratories Ltd.